QSAR Studies for the Pharmacological Inhibition of Glycogen Synthase Kinase-3

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|3|4|393-417

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.3, Iss.4, 2007-07, pp. : 393-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3028-3034

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 3, 2013-05 ,pp. : 436-443

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1377-1388

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1421-1434

Bentham Science Publishers

Access to resources Recommend Favorite